Verve Therapeutics
Caroline Reiss is an associate principal scientist, RNA technology at Verve Therapeutics, with expertise in production and characterization of RNA molecules. Prior to the joining Verve, Dr. Reiss worked as a development scientist at Casebia Therapeutics, manufacturing mRNA for gene editing therapeutics. She received her B.S. in biochemistry from Trinity College and her Ph.D. in molecular biophysics and biochemistry from Yale University, where she published three X-ray crystal structures of RNA aptamers in complex with their native small-molecule ligands.
This person is not in any offices
Verve Therapeutics
59 followers
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.